文献速递区域麻醉与超声疼痛医学

脂质体布比卡因与标准布比卡因联合地塞米松肌间沟臂丛阻滞的非劣效性试验

Interscalene Brachial Plexus Block with Liposomal Bupivacaine versus Standard Bupivacaine with Perineural Dexamethasone: A Noninferiority Trial.
PubMed 文献 · Anesthesiology · 2022-01-01

这项随机双盲非劣效性试验纳入112例门诊肩部手术患者,比较脂质体布比卡因与标准布比卡因联合地塞米松肌间沟臂丛阻滞的镇痛效果。主要结局为术后72小时静息数字评分法疼痛评分均值,脂质体布比卡因组不劣于标准布比卡因联合地塞米松组。两组在阻滞持续时间、运动与感觉恢复、阿片类药物消耗、麻醉后监护室出室准备及不良事件方面无显著差异。

要点

  • 脂质体布比卡因组术后72小时平均静息疼痛评分不劣于标准布比卡因联合地塞米松组。
  • 两组镇痛持续时间、运动与感觉恢复时间、阿片消耗及不良事件无显著差异。
  • 标准布比卡因联合地塞米松可与脂质体布比卡因互换用于肩部手术后镇痛。

核心结论

  • 肌间沟臂丛阻滞使用脂质体布比卡因提供的有效镇痛与标准布比卡因联合地塞米松相似。
  • 标准布比卡因联合地塞米松可与脂质体布比卡因互换用于肩部手术后镇痛。

研究设计与样本

  • 随机双盲非劣效性试验,共纳入112例接受门诊肩部手术的患者。
  • 脂质体布比卡因组55例,接受10 ml含133 mg脂质体布比卡因与5 ml 0.5%布比卡因的15 ml预混液。
  • 布比卡因联合地塞米松组56例,接受15 ml 0.5%标准布比卡因与4 mg地塞米松的混合液。
  • 主要结局为术后72小时静息数字评分法疼痛评分均值,非劣效性界值为1.3。

主要发现

  • 脂质体布比卡因组72小时平均数字评分法疼痛评分不劣于布比卡因联合地塞米松组(均值[标准差] 2.4[1.9] vs. 3.4[1.9];均值差[95%CI] -1.1[-1.8, -0.4];非劣效性P<0.001)。
  • 两组镇痛持续时间无显著差异(26[20, 42]小时 vs. 27[20, 39]小时;P=0.851)。
  • 两组运动恢复时间相似(27(21, 48)小时 vs. 27(19, 40)小时;P=0.436),感觉恢复时间相似(27[21, 44]小时 vs. 31(20, 42)小时;P=0.862)。
  • 两组阿片类药物消耗、麻醉后监护室出室准备及不良事件无差异。

临床怎么用

  • 对于肩部手术的肌间沟臂丛阻滞,标准布比卡因联合地塞米松可作为脂质体布比卡因的替代方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The interscalene nerve block provides analgesia for shoulder surgery. To extend block duration, provide adequate analgesia, and minimize opioid consumption, the use of adjuvants such as dexamethasone as well as the application of perineural liposomal bupivacaine have been proposed. This randomized, double-blinded, noninferiority trial hypothesized that perineural liposomal bupivacaine is noninferior to standard bupivacaine with perineural dexamethasone in respect to average pain scores in the first 72 h after surgery. METHODS: A total of 112 patients undergoing ambulatory shoulder surgery were randomized into two groups. The liposomal bupivacaine group received a 15-ml premixed admixture of 10 ml of 133 mg liposomal bupivacaine and 5 ml of 0.5% bupivacaine (n = 55), while the bupivacaine with dexamethasone group received an admixture of 15 ml of 0.5% standard bupivacaine with 4 mg dexamethasone (n = 56), respectively. The primary outcome was the average numerical rating scale pain scores at rest over 72 h. The mean difference between the two groups was compared against a noninferiority margin of 1.3. Secondary outcomes were analgesic block duration, motor and sensory resolution, opioid consumption, numerical rating scale pain scores at rest and movement on postoperative days 1 to 4 and again on postoperative day 7, patient satisfaction, readiness for postanesthesia care unit discharge, and adverse events. RESULTS: A liposomal bupivacaine group average numerical rating scale pain score over 72 h was not inferior to the bupivacaine with dexamethasone group (mean [SD], 2.4 [1.9] vs. 3.4 [1.9]; mean difference [95% CI], -1.1 [-1.8, -0.4]; P < 0.001 for noninferiority). There was no significant difference in duration of analgesia between the groups (26 [20, 42] h vs. 27 [20, 39] h; P = 0.851). Motor and sensory resolutions were similar in both groups: 27 (21, 48) h versus 27 (19, 40) h (P = 0.436) and 27 [21, 44] h versus 31 (20, 42) h (P = 0.862), respectively. There was no difference in opioid consumption, readiness for postanesthesia care unit discharge, or adverse events. CONCLUSIONS: Interscalene nerve blocks with perineural liposomal bupivacaine provided effective analgesia similar to the perineural standard bupivacaine with dexamethasone. The results show that bupivacaine with dexamethasone can be used interchangeably with liposomal bupivacaine for analgesia after shoulder surgery.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Kim DH, Liu J, Beathe JC, et al. Interscalene Brachial Plexus Block with Liposomal Bupivacaine versus Standard Bupivacaine with Perineural Dexamethasone: A Noninferiority Trial. Anesthesiology. 2022. PMID: 35041742. doi:10.1097/ALN.0000000000004111

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。